Elevation Oncology Inc. (NASDAQ: ELEV) Stock Information | RedChip

Elevation Oncology Inc. (NASDAQ: ELEV) Listen to this Section


$0.71
-0.0102 ( -1.41% ) 539.1K

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

Market Data


Open


$0.71

Previous close


$0.72

Volume


539.1K

Market cap


$42.01M

Day range


$0.71 - $0.74

52 week range


$0.36 - $5.83

Insider Ownership Transactions

Total Amount Purchased: -1,202,102.00 | $ -855,656.20

Date Type Amount Purchased Purchaser
2024-03-04 Sale -55000.00 Cherrington Julie M
2024-02-20 Sale -225000.00 Jansen Valerie Malyvanh
2024-02-20 Sale -1200.00 Furlong Tammy
2024-02-20 Sale -225000.00 Dornan David
2024-02-20 Sale -600000.00 Ferra Joseph J Jr
2024-01-22 Sale -55000.00 Mootz Darcy
2023-12-19 Sale -12563.00 Ferra Joseph J Jr
2023-09-19 Sale -12562.00 Ferra Joseph J Jr
2023-09-05 Sale -15777.00 CLACKSON TIMOTHY P

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 May 17, 2024
10-q Quarterly Reports 79 May 02, 2024
8-k 8K-related 16 May 02, 2024
ars Annual reports 1 Apr 26, 2024
def Proxies and info statements 4 Apr 26, 2024
8-k 8K-related 15 Apr 05, 2024
4 Insider transactions 1 Mar 19, 2024
10-k Annual reports 98 Mar 06, 2024
8-k 8K-related 16 Mar 06, 2024
4 Insider transactions 1 Mar 04, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.